Evidence map›Paper›PMID 37721127›Full record

Trial reportBalkan medical journal2023

Does Maintaining a Targeted Abdominal Perfusion Pressure Reduce Renal Damage in Patients with Septic Shock?: A Randomized, Controlled, and Open-label Study

Hüseyin Özkarakaş, Zeki Tuncel Tekgül, Murat Arslan, Mehmet Uğur Bilgin, Hazal Ezgi Eker, Onur Okur, Bülent Çalık

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Balkan medical journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Hüseyin ÖzkarakaşClinic of Intensive Care, University of Health Sciences Türkiye, İzmir Bozyaka Trainig and Research Hospital, İzmir, TürkiyeORCID 0000-0002-3897-9985
Zeki Tuncel TekgülClinic of Intensive Care, University of Health Sciences Türkiye, İzmir Bozyaka Trainig and Research Hospital, İzmir, TürkiyeORCID 0000-0002-2728-8185
Murat ArslanClinic of Intensive Care, University of Health Sciences Türkiye, İzmir Bozyaka Trainig and Research Hospital, İzmir, TürkiyeORCID 0000-0002-5367-547X
Mehmet Uğur BilginClinic of Anesthesiology and Reanimation, Helios Klinikum Schleswig, Teaching Hospital for the University of Kiel, Kiel, GermanyORCID 0000-0003-4198-1450
Hazal Ezgi EkerClinic of Anesthesiology and Reanimation, İzmir Bayındır State Hospital, İzmir, TürkiyeORCID 0000-0001-8826-2838
Onur OkurClinic of Anesthesiology and Reanimation, University of Health Sciences Türkiye, Prof. Dr. Cemil Taşcıoğlu Training and Research Hospital, İstanbul, TürkiyeORCID 0000-0001-6769-2054
Bülent ÇalıkClinic of Intensive Care, University of Health Sciences Türkiye, İzmir Bozyaka Trainig and Research Hospital, İzmir, TürkiyeORCID 0000-0002-9054-1446
Sağlık Bilimleri Üniversitesi · TRIzmir Bozyaka Eğitim ve Araştırma Hastanesi · TRTürk Anesteziyoloji ve Reanimasyon Derneği · TRUniversity Hospital Schleswig-Holstein · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Increased intra-abdominal pressure (IAP) in patients admitted to the intensive care unit leads to reduced abdominal perfusion pressure (APP), causing circulatory insufficiency and organ failure. Aims: To investigate the effect of maintaining a targeted APP on renal injury and the effect of increased IAP on the mortality rate in patients with septic shock. Study Design: Randomized, controlled, open-label study. Methods: A total of 72 patients were randomly divided into two groups (MAP65 or APP60). The MAP target for patients in the MAP65 group (n = 36) was 65 mmHg according to the Surviving Sepsis Guidelines. In the APP60 group (n = 36), the target APP was set to > 60 mmHg. The glomerular filtration rate (GFR), inotrope consumption, and IAP were recorded daily. The need for renal replacement therapy, decrease in GFR, and 30- and 90-day mortality rates were compared between the two groups. Results: In both the groups, the IAP was statistically similar ( Conclusion: Setting an APP target limited the reduction in GFR. The mortality rates were similar in the two groups and there was no difference in the rate of end-stage renal failure between the groups.

Indexed as

Shock, SepticAbdomenHumansKidneyPerfusionProspective Studies

Identifiers

PMID37721127
PMCPMC10613750
OpenAlexW4386817657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.